Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Biologics CDMO Market: Industry Overview, Regional Analysis, and Forecast to 2033The global biopharmaceutical industry is undergoing a transformative shift as biologics continue to dominate drug pipelines and therapeutic innovations. In this evolving ecosystem, Biologics Contract Development and Manufacturing Organizations (CDMOs) play a critical role by providing specialized services that support the development, production, and commercialization of complex biologic drugs....0 Comentários 0 Compartilhamentos 603 Visualizações 0 Anterior
-
Bioprocess Containers Market to Hit USD 4.18 Billion by 2032“According to a new report published by Introspective Market Research, the Bioprocess Containers Market by Product Type, Material, and End User, the Global Bioprocess Containers Market Size was Valued at USD 2.14 Billion in 2023 and is Projected to Reach USD 4.18 Billion by 2032, Growing at a CAGR of 12.2%.” The bioprocess containers market plays a vital role in modern...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
cGMP Process Development Market to Reach USD 6.06 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global cGMP Process Development market was valued at USD 3.75 billion in 2025 and is projected to reach USD 6.06 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025–2032. cGMP process development represents the critical discipline of systematically designing,...0 Comentários 0 Compartilhamentos 526 Visualizações 0 Anterior
-
Contract Manufacturing Boom Supporting API CDMO Market ExpansionRegulatory complexity in drug manufacturing is encouraging companies to rely on specialized CDMOs.Expert compliance management reduces operational risks and delays.This support is critical for global market expansion. Active Pharmaceutical Ingredients CDMO market The market is expected to grow steadily at a CAGR of 7.4% from 2025 to 2031, driven by innovation in drug development and the global...0 Comentários 0 Compartilhamentos 5KB Visualizações 0 Anterior2